| FarmaSino Pharmaceuticals (Anhui) Co., Ltd is a leading manufacturer of APIs, Intermediates and Fine Chemicals. It located in the Fine Chemical Base of Wujiang, and is very closed to Nanjing within 50km. FarmaSino was established in 2005, covering an area over 35,000sqm, it has top-level chemical synthesis workshop and APIs workshop which are in accordance with GMP requirements. Now we have over 80 employees including 32 engineering technicians. Relying on the continuous innovation in research and development technique, increasingly perfect quality management and supplying prompt and thoughtful sales services. All of these have made FarmaSino became a most important supplier for many international pharmaceutical companies in the world. |
| |
| Fosfomycin Trometamol, Fosfomycin Phenylethylamine, Fosfomycin Sodium, Fosfomycin Calcium,L-Theanine, Cefprozil, Mildronate, Diethyl iminodiacetate, N-Methylphthalimide and 2-Chlorodiphenyl Ether etc. are the leading products of FarmaSino. And it also undertakes the Custom Synthesis services as R&D, pilot-scale and commercial production of all kinds of fine chemicals, and the quantity size is from mg to tons. We always provide competitive price and perfect quality with good services for kinds of contract manufacturing requirement of our clients. |
| |
| FarmaSino has a R&D Center over 4, 000 square meters in Nanjing, which is equipped of a high standard laboratory with a complete set of technical analytical equipments and instruments. We also have a team work of professional technical engineers with well-trained, good experiences and dynamic to ensures on-time delivery, cost saving and high quality. |
| |
| FarmaSino holds up the mission that “pursuit of customer satisfaction is our responsibility”, and the core value is “Develop together, gain the future”. “Honesty and faith, corporation, Execute power” is Our business philosophy, and “Be professional, concentrated and be attention on the human health” is Our Vision. We look forward to successfully cooperation with you in future. |
